Current CDC FluSurv-NET surveillance shows laboratory-confirmed influenza hospitalization rates have fallen to 0.5 per 100,000 in recent weeks, with national admissions projected to stay between 320 and 2,400 for the week ending May 23. This steep seasonal decline after a cumulative rate of 85.2 per 100,000 through mid-April means week 19 is expected to add only minimal new cases, anchoring the final cumulative figure firmly in the 85–90 range. Historical patterns confirm that May activity remains near baseline once transmission drops below epidemic thresholds. Any modest upward revision would require an atypical late-season resurgence exceeding current model consensus, an outcome not supported by ongoing virologic or syndromic trends.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoFlu Hospitalization Rate Week 19, 2026?
Flu Hospitalization Rate Week 19, 2026?
85–90 97.8%
80–85 1.7%
100+ <1%
95–100 <1%
NOWE
NOWE
May 22, 2026
<80
1%
80–85
2%
85–90
98%
90–95
<1%
95–100
1%
100+
1%
85–90 97.8%
80–85 1.7%
100+ <1%
95–100 <1%
NOWE
NOWE
May 22, 2026
<80
$758 Wol.
1%
80–85
$2,620 Wol.
2%
85–90
$1,140 Wol.
98%
90–95
$340 Wol.
<1%
95–100
$548 Wol.
1%
100+
$381 Wol.
1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Current CDC FluSurv-NET surveillance shows laboratory-confirmed influenza hospitalization rates have fallen to 0.5 per 100,000 in recent weeks, with national admissions projected to stay between 320 and 2,400 for the week ending May 23. This steep seasonal decline after a cumulative rate of 85.2 per 100,000 through mid-April means week 19 is expected to add only minimal new cases, anchoring the final cumulative figure firmly in the 85–90 range. Historical patterns confirm that May activity remains near baseline once transmission drops below epidemic thresholds. Any modest upward revision would require an atypical late-season resurgence exceeding current model consensus, an outcome not supported by ongoing virologic or syndromic trends.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Rynek otwarty: May 14, 2026, 7:51 PM ET
Wolumen
$5,788Data zakończenia
May 22, 2026Rynek otwarty
May 14, 2026, 7:51 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Current CDC FluSurv-NET surveillance shows laboratory-confirmed influenza hospitalization rates have fallen to 0.5 per 100,000 in recent weeks, with national admissions projected to stay between 320 and 2,400 for the week ending May 23. This steep seasonal decline after a cumulative rate of 85.2 per 100,000 through mid-April means week 19 is expected to add only minimal new cases, anchoring the final cumulative figure firmly in the 85–90 range. Historical patterns confirm that May activity remains near baseline once transmission drops below epidemic thresholds. Any modest upward revision would require an atypical late-season resurgence exceeding current model consensus, an outcome not supported by ongoing virologic or syndromic trends.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Wolumen
$5,788Data zakończenia
May 22, 2026Rynek otwarty
May 14, 2026, 7:51 PM ETResolver
0x69c47De9D...Current CDC FluSurv-NET surveillance shows laboratory-confirmed influenza hospitalization rates have fallen to 0.5 per 100,000 in recent weeks, with national admissions projected to stay between 320 and 2,400 for the week ending May 23. This steep seasonal decline after a cumulative rate of 85.2 per 100,000 through mid-April means week 19 is expected to add only minimal new cases, anchoring the final cumulative figure firmly in the 85–90 range. Historical patterns confirm that May activity remains near baseline once transmission drops below epidemic thresholds. Any modest upward revision would require an atypical late-season resurgence exceeding current model consensus, an outcome not supported by ongoing virologic or syndromic trends.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania